Recruiting NA INTERVENTIONAL 2-arm NCT06631820

The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD (EPIC-CKD)

The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD: a Pilot Study (EPIC-CKD)

Sponsor: Karolinska Institutet

Conditions Chronic Kidney Disease(CKD) Mitochondrial Dysfunction Muscle Function Muscle Mass Myosteatosis

Interventions Epicatechin extract

Updated 2 times since 2024 Last updated: Jul 7, 2025 Started: Jan 17, 2025 Primary completion: Jan 31, 2026 Completion: Oct 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06631820, this NA trial focuses on Chronic Kidney Disease(CKD) and Mitochondrial Dysfunction and remains actively recruiting participants. Sponsored by Karolinska Institutet, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Aug 2025 — Present [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Nov 2024 — Aug 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karolinska Institutet

Data source: Karolinska Institutet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Huddinge, Sweden